GHB differentially affects morphine actions on motor activity and social behaviours in male mice

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 2, 2003, Pages 259-265

  Maldonado, C ^a   Rodriguez Arias M ^a   Aguilar, M A ^a   Minarro J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aggression; GHB; Mice; Morphine; Motor activity; Social contacts

Indexed keywords

4 HYDROXYBUTYRIC ACID; MORPHINE; OPIATE RECEPTOR;

ACTIMETRY; AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXPLORATORY BEHAVIOR; HYPERACTIVITY; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

EID: 0142165020     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00222-3     Document Type: Article

References (62)

1. Aguilar M.A., Miñarro J., Pérez-Iranzo N., Simón V.M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47:1994;753-756.
2. Banvides J., Rumugny J.F., Bourguignon J.J., Cash C., Wernuth C.G., Mandel P.et al. High affinity binding site for γ-hydroxybutyric acid in rat brain. Life Sci. 30:1982;953-961.
3. Bernasconi R., Mathivet P., Bischoff S., Marescaux C. Gamma-hydroxybutyric acid: an endogenous modulator with potential abuse? TIPS. 20:1999;135-141.
4. Bexis S., Ong J., White J. Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen. Life Sci. 70:2001;395-401.
5. Bjork J.M., Moeller F.G., Kramer G.L., Kram M., Suris A., Rush A.J.et al. Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder. Psych. Res. 1001:2001;131-136.
6. Brain P.F., McAllister K.H., Walmsley S.V. Drug effects on social behaviors. Boulton A.A., Baker G.B., Greenshaw A.J. Methods in ethopharmacology. Psychopharmacology (series: Neuromethods, vol. 13). 1989;687-739 The Humana Press, Clifton (NJ).
7. Broughton R., Mamelak M. The treatment of narcolepsy-catalepsy with nocturnal gamma-hydroxybutyrate. Can. J. Neurol. Sci. 6:1979;1-6.
8. Cherek D.R., Lane S.D., Pietrans C.J., Sharon J., Steinberg J.L. Acute effects of baclofen, a γ-aminobutyric acid-B agonist, on laboratory measures of aggressive and escape responses of adult male parolees with and without a history of conduct disorder. Psychopharmacology. 164:2002;160-167.
9. Cook C.D., Aceto M.D., Coop A., Beardsley P.M. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gamma-hydroxybutyrate in mice. Psychopharmacology. 160:2002;99-106.
10. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5274-5278.
11. Fattore L., Martellotta M.C., Cossu G., Fratta W. Gamma-hydroxybutyric acid. An evaluation of its rewarding properties in rats and mice. Alcohol. 20:2000;247-256.
12. Feigenbaum J.J., Howards G. Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study. Neurosci. Lett. 224:1997;71-74.
13. Feigenbaum J.J., Simantov R. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding. Neurosci. Lett. 212:1996;5-8.
14. Gallimberti L., Gantile N., Cibin M., Fadda F., Canton G., Ferri M.et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet. 1989;787-789.
15. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol. Clin. Exp. Res. 16:1992;673-676.
16. Gallimberti L., Cibin M., Pagnin P., Sabbion R., Pani P.P., Pirastu R.et al. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:1993;77-81.
17. Gallimberti L., Schifano F., Forza G., Miconi L., Ferrara S.D. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur. Arch. Psychiatry Clin. Neurosci. 244:1994;113-114.
18. Gessa G.L., Vatgui L., Crabai F., Boero G.C., Caboni F., Camba R. Selective increase of brain dopamine induced by γ-hydroxybutyrate. Life Sci. 5:1966;1921-1930.
19. Gobaille S., Schmidt C., Cupo A., Herbrecht F., Maitre M. Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels. Neuroscience. 60:1994;637-648.
20. Ho L.K., Loh H.H., Way E.L. Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. Life Sci. 18:1976;1111-1124.
21. Itzhak Y., Ali S.F. Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann. N. Y. Acad. Sci. 965:2002;451-460.
22. Iwamoto E.T. Locomotor activity and antinoception after putative and opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists. J. Pharmacol. Exp. Ther. 217:1981;451-460.
23. Krsiak M., Sulcova A., Tomasikova Z., Dlohozkova N., Kosar E., Masek K. Drug effect on attack, defence and escape in mice. Pharmacol. Biochem. Behav. 14:1981;47-52.
24. Kudryavtseva N., Lipina T.V., Koryakina L. Effects of Haloperidol on communicative and aggressive behavior in male mice with different experiences of aggression. Pharmacol. Biochem. Behav. 63:1999;229-236.
25. Laborit G., Larcan A., Kind A. Le gamma-hydroxybutyrate en anesthesieneuro-cirurgicale. Neurochirurgie. 8:1962;104-107.
26. Lason W., Przewlocka B., Przewlocki R. The effect of gamma- hydroxybutyrate and anticonvulsants on opioid content in the rat brain. Life Sci. 33:1983;599-602.
27. Maiewski S.F., Larscheid P., Cook J.M., Mueller G.P. Evidence that a benzodiazepine receptor mechanism regulates the secretion of pituitary beta-endorphin in rats. Endocrinology. 117:1985;474-480.
28. Maitre M. The γ-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51:1997;337-361.
29. Manier M., Abrons D.N., Feuerstein C., Le Moal M., Herman J.P. Increase in methionin-enkephalin content following lesion of nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immuno-histochemical analysis. Neuroscience. 42:1991;427-439.
30. Miczek K.A., Fish E.W., Bold J.F., Almeida R.M.M. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid system. Psychopharmacology. 163:2002;434-458.
31. Miñarro J., Castaño D., Brain P.F., Simón V.M. Haloperidol does not antagonize the effects of stress on aggressive behaviour in mice. Physiol. Behav. 47:1990;281-287.
32. Morgenroth V.H., Walters J.R., Roth R.H. Dopaminergic neurons: alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochem. Pharmacol. 25:1976;655-661.
33. Navarro J.F., Pedraza M.C. An ethopharmacological assessment of the effects of gammahydroxybutyrate (GHB) on agonistic interactions in male mice. Med. Sci. Res. 24:1996;817-819.
34. Navarro J.F., Martín-López M., Manzaneque J.M., Pedraza C., Dávila G. Dose-dependent effect of gammahydroxybutyrate (GHB) on catalepsy in male mice. Med. Sci. Res. 24:1996;603-604.
35. Nicholson K.L., Balster R.L. GHB: a new novel drug of abuse. Drug Alcohol Depend. 63:2001;1-22.
36. Nissbrandt H., Elverfors A., Engberg G. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux. Synapse. 17:1994;217-224.
37. Poshivalov V.P. Pharmaco-ethological analysis of social behavior in isolated mice. Pharmacol. Biochem. Behav. 14:1981;53-59.
38. Puglisi-Allegra S., Simler S., Kempf E., Mandel P. Involvement of the GABAergic system on shock-induced aggressive behavior in two strains of mice. Pharmacol. Biochem. Behav. 14:1981;13-18.
39. Rattan A.K., Sribanditmongkol P. Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol. Biochem. Behav. 48:1994;357-361.
40. Redolat R., Brain P.F., Simon V.M. Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology. 30:1991;41-46.
41. Rodríguez-Arias M., Miñarro J., Simón V.M. Interaction of morphine and haloperidol on agonistic behavior in male mice. Pharmacol. Biochem. Behav. 58:1997;153-158.
42. Rodríguez-Arias M., Miñarro J., Aguilar M.A., Simón V.M. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur. Neuropsycopharmacol. 8:1998;95-103.
43. a maleate increases social behaviors in isolation-induced aggressive male mice. Psychopharmacology. 144:1999;90-94.
44. Rodríguez-Arias M., Broseta I., Aguilar M.A., Miñarro J. Lack of specific effects of selective d1 and d2 dopamine antagonists vs risperidone on morphine-induced hyperactivity. Pharmacol. Biochem. Behav. 66:2000;189-197.
45. Rodríguez-Arias M., Maldonado C., Aguilar M.A., Miñarro J. Memantine blocks motor but not antiaggressive effects of morphine. Behav. Pharmacol. 13:2002;249-252.
46. Roth R.H., Doherty J.D., Walters J.R. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Res. 189:1980;556-560.
47. Sasaki K., Fan L.W., Tien L.T., Ma T., Loh H.H., Ho I.K. The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain Res. Bull. 57:2002;689-694.
48. Schmidt-Mutter C., Pain L., Sandner G., Gobaille S., Maitre M. The anxiolytic effect of g-hydroxybutyrate in the elevated plus-maze is reversed by the benzodiacepine receptor antagonist, flumazenil. Eur. J. Pharmacol. 342:1998;21-27.
49. Schmidt-Mutter C., Gobaille S., Muller C., Maitre M. Prodynorphin and proenkephalin mRNA are increased in rat brain after acute and chronic administration of gamma-hydroxybutyrate. Neurosci. Lett. 262:1999;65-68.
50. Smoothy R., Brain P.F., Berry M.S., Haug M. Alcohol and social behaviour in group-housed female mice. Physiol. Behav. 37:1986;689-694.
51. Snead O.C., Bearden L.J. Naloxone overcomes the dopaminergic EEG and behavioural effects of g-hydroxybutyrate. Neurology. 30:1980;832-838.
52. Snead O.C., Bearden L.J. The epileptogenic spectrum of opiate agonists. Neuropharmacology. 21:1982;1137-1144.
53. Spano P.F., Tagliamonte A., Tagliamonte P., Gessa G.L. Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate. J. Neurochem. 18:1971;1831-1836.
54. Stell J.M., Ryan J.M. Gamma-hydroxybutyrate is a new recreational drug that may lead to loss of consciousness. BMJ. 313:1996;424.
55. Tang F., Costa E., Schwartz J.P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after injection of haloperidol for 2 or 3 weeks. Proc. Natl. Acad. Sci. U. S. A. 80:1983;3841-3844.
56. Tidey J.W., Miczek K.A. Morphine withdrawal aggression: modifications with D1 and D2 receptor agonists. Psychopharmacology. 108:1992;177-184.
57. Vayer P., Maitre M. γ-Hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices. J. Neurochem. 52:1989;1382-1387.
58. Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41:1987;1547-1557.
59. Winslow J.T., Miczek K.A. Naltrexone blocks amphetamine-induced hyperactivity but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology. 96:1988;493-499.
60. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
61. Zarrindast M.R., Mousa-Ahmadi E. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur. J. Pharmacol. 381:1999;129-133.
62. Zerbib R., Pierrefiche G., Ferran C., Laborit H. Potential antidepressant activity of gamma-hydroxybutyrate in the mouse "behavioral despair" test: correlation with the central dopaminergic system. Res. Commun. Psychol. Psych. Behav. 17:1992;109-122.